BIONUTRICS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIONUTRICS
Largest movements
- Receivables within one year +€471,348
up €471,348 (+4.2%), from €11.2m to €11.7m
of which Other amounts receivable: +€469,925
- Profit (loss) carried forward +€254,273
up €254,273 (+2.3%), from €11.1m to €11.3m
- Trade debts +€164,854
up €164,854 (+635%), from €25,976 to €190,830
- Turnover -€11.6m
no longer reported in 2025 (was €11.6m)
- Goods and materials -€4.7m
down €4.7m, from €4.7m to -€17
of which Purchases: -€4.7m
- Services and other goods -€4.5m
down €4.5m (-91.1%), from €4.9m to €439,087
- Staff costs -€2.9m
down €2.9m (-99.9%), from €2.9m to €3,850
- Taxes -€770,639
down €770,639 (-89.0%), from €865,642 to €95,003
of which Taxes: -€773,019
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €11,600,009 | €11,973,667 | +€373,659 | +3.2% |
| Current assets | 29/58 | €11,600,009 | €11,973,667 | +€373,659 | +3.2% |
| Amounts receivable within one year | 40/41 | €11,242,039 | €11,713,387 | +€471,348 | +4.2% |
| Trade receivables | 40 | €15,234 | €16,658 | +€1,423 | +9.3% |
| Other amounts receivable | 41 | €11,226,805 | €11,696,729 | +€469,925 | +4.2% |
| Cash at bank and in hand | 54/58 | €350,703 | €252,791 | -€97,912 | -27.9% |
| Deferred charges and accrued income | 490/1 | €7,267 | €7,490 | +€223 | +3.1% |
| Total equity and liabilities | 10/49 | €11,600,009 | €11,973,667 | +€373,659 | +3.2% |
| Equity | 10/15 | €11,272,224 | €11,526,498 | +€254,273 | +2.3% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Capital | 10 | €200,000 | €200,000 | = | 0.0% |
| Issued capital | 100 | €200,000 | €200,000 | = | 0.0% |
| Reserves | 13 | €20,057 | €20,057 | = | 0.0% |
| Non-distributable reserves | 130/1 | €20,000 | €20,000 | = | 0.0% |
| Legal reserve | 130 | €20,000 | €20,000 | = | 0.0% |
| Tax-exempt reserves | 132 | €57 | €57 | = | 0.0% |
| Profit (loss) carried forward | 14 | €11,052,167 | €11,306,441 | +€254,273 | +2.3% |
| Provisions and deferred taxes | 16 | €68,000 | €68,000 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €68,000 | €68,000 | = | 0.0% |
| Taxes | 161 | €60,000 | €60,000 | = | 0.0% |
| Other liabilities and charges | 164/5 | €8,000 | €8,000 | = | 0.0% |
| Amounts payable | 17/49 | €259,784 | €379,170 | +€119,385 | +46.0% |
| Amounts payable within one year | 42/48 | €251,968 | €370,130 | +€118,162 | +46.9% |
| Trade debts | 44 | €25,976 | €190,830 | +€164,854 | +635% |
| Suppliers | 440/4 | €25,976 | €190,830 | +€164,854 | +635% |
| Taxes, remuneration and social security | 45 | €225,992 | €179,300 | -€46,692 | -20.7% |
| Taxes | 450/3 | €68,022 | €75,144 | +€7,122 | +10.5% |
| Remuneration and social security | 454/9 | €157,970 | €104,156 | -€53,814 | -34.1% |
| Accrued charges and deferred income | 492/3 | €7,817 | €9,040 | +€1,223 | +15.6% |
| Operating income | 70/76A | €16,421,761 | €398,086 | -€16.0m | -97.6% |
| Turnover | 70 | €11,635,277 | - | -€11.6m | |
| Other operating income | 74 | €608,483 | €398,086 | -€210,397 | -34.6% |
| Non-recurring operating income | 76A | €4,178,000 | - | -€4.2m | |
| Operating charges | 60/66A | €12,439,242 | €446,084 | -€12.0m | -96.4% |
| Goods for resale, raw materials and consumables | 60 | €4,696,382 | -€17 | -€4.7m | |
| Purchases | 600/8 | €4,696,348 | - | -€4.7m | |
| Change in stocks: decrease (increase) | 609 | €33 | -€17 | -€50 | |
| Services and other goods | 61 | €4,909,915 | €439,087 | -€4.5m | -91.1% |
| Remuneration, social security and pensions | 62 | €2,903,647 | €3,850 | -€2.9m | -99.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,529 | - | -€12,529 | |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€9,163 | - | +€9,163 | |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | -€91,271 | - | +€91,271 | |
| Other operating charges | 640/8 | €2,755 | €3,164 | +€409 | +14.9% |
| Non-recurring operating charges | 66A | €14,449 | - | -€14,449 | |
| Operating profit (loss) | 9901 | €3,982,519 | -€47,998 | -€4.0m | |
| Financial income | 75/76B | €341,777 | €402,268 | +€60,491 | +17.7% |
| Recurring financial income | 75 | €341,777 | €402,268 | +€60,491 | +17.7% |
| Income from current assets | 751 | €341,578 | €400,147 | +€58,569 | +17.1% |
| Other financial income | 752/9 | €200 | €2,122 | +€1,922 | +962% |
| Financial charges | 65/66B | €160,874 | €4,993 | -€155,881 | -96.9% |
| Recurring financial charges | 65 | €160,874 | €4,993 | -€155,881 | -96.9% |
| Other financial charges | 652/9 | €160,874 | €4,993 | -€155,881 | -96.9% |
| Profit (loss) for the period before taxes | 9903 | €4,163,421 | €349,277 | -€3.8m | -91.6% |
| Income taxes | 67/77 | €865,642 | €95,003 | -€770,639 | -89.0% |
| Taxes | 670/3 | €868,022 | €95,003 | -€773,019 | -89.1% |
| Tax adjustments and reversals of tax provisions | 77 | €2,380 | - | -€2,380 | |
| Profit (loss) for the period | 9904 | €3,297,779 | €254,273 | -€3.0m | -92.3% |
| Profit (loss) for the period to be appropriated | 9905 | €3,297,779 | €254,273 | -€3.0m | -92.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.